These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1515210)

  • 1. Study of the interaction of HIV-1 and HIV-2 envelope glycoproteins with the CD4 receptor and role of N-glycans.
    Bahraoui E; Benjouad A; Guetard D; Kolbe H; Gluckman JC; Montagnier L
    AIDS Res Hum Retroviruses; 1992 May; 8(5):565-73. PubMed ID: 1515210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction by human immunodeficiency viruses types 1 and 2 of degradation of CD4 but not of a CD4 mutant unable to bind viral envelope glycoproteins.
    Cucchiarini M; Cagnon L; Giordanengo V; Doglio A; Lefebvre JC
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Apr; 8(5):427-36. PubMed ID: 7697438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Properties of HIV membrane reconstituted from its recombinant gp160 envelope glycoprotein.
    Cornet B; Decroly E; Thines-Sempoux D; Ruysschaert JM; Vandenbranden M
    AIDS Res Hum Retroviruses; 1992 Oct; 8(10):1823-31. PubMed ID: 1457195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological properties of recombinant HIV envelope synthesized in CHO glycosylation-mutant cell lines.
    Fenouillet E; Miquelis R; Drillien R
    Virology; 1996 Apr; 218(1):224-31. PubMed ID: 8615025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of N-linked glycans in the interaction between the envelope glycoprotein of human immunodeficiency virus and its CD4 cellular receptor. Structural enzymatic analysis.
    Fenouillet E; Clerget-Raslain B; Gluckman JC; Guétard D; Montagnier L; Bahraoui E
    J Exp Med; 1989 Mar; 169(3):807-22. PubMed ID: 2538547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-linked oligosaccharides of simian immunodeficiency virus envelope glycoproteins are dispensable for the interaction with the CD4 receptor.
    Benjouad A; Babas T; Montagnier L; Bahraoui E
    Biochem Biophys Res Commun; 1993 Jan; 190(2):311-9. PubMed ID: 8427576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-linked glycans in the CD4-binding domain of human immunodeficiency virus type 1 envelope glycoprotein gp160 are essential for the in vivo priming of T cells recognizing an epitope located in their vicinity.
    Sjölander S; Bolmstedt A; Akerblom L; Horal P; Olofsson S; Morein B; Sjölander A
    Virology; 1996 Jan; 215(2):124-33. PubMed ID: 8560759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of endoproteolytic cleavage and intracellular transport of human immunodeficiency virus type 1 envelope glycoproteins using mutant CD4 molecules bearing the transmembrane endoplasmic reticulum retention signal.
    Raja NU; Vincent MJ; Jabbar MA
    J Gen Virol; 1993 Oct; 74 ( Pt 10)():2085-97. PubMed ID: 8409933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The glycosylation of human immunodeficiency virus type 1 transmembrane glycoprotein (gp41) is important for the efficient intracellular transport of the envelope precursor gp160.
    Fenouillet E; Jones IM
    J Gen Virol; 1995 Jun; 76 ( Pt 6)():1509-14. PubMed ID: 7782780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Processing and routage of HIV glycoproteins by furin to the cell surface.
    Moulard M; Hallenberger S; Garten W; Klenk HD
    Virus Res; 1999 Mar; 60(1):55-65. PubMed ID: 10225274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycosylation and stability of mature HIV envelope glycoprotein conformation under various conditions.
    Papandreou MJ; Idziorek T; Miquelis R; Fenouillet E
    FEBS Lett; 1996 Jan; 379(2):171-6. PubMed ID: 8635586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of carbohydrate moieties on the immunogenicity of human immunodeficiency virus type 1 recombinant gp160.
    Benjouad A; Gluckman JC; Rochat H; Montagnier L; Bahraoui E
    J Virol; 1992 Apr; 66(4):2473-83. PubMed ID: 1347797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the human immunodeficiency virus type 1 envelope protein interaction with the CD4 host cell receptor.
    Malvoisin E; Wild F
    J Gen Virol; 1994 Apr; 75 ( Pt 4)():839-47. PubMed ID: 8151300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. gp160 of HIV-I synthesized by persistently infected Molt-3 cells is terminally glycosylated: evidence that cleavage of gp160 occurs subsequent to oligosaccharide processing.
    Merkle RK; Helland DE; Welles JL; Shilatifard A; Haseltine WA; Cummings RD
    Arch Biochem Biophys; 1991 Oct; 290(1):248-57. PubMed ID: 1898096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Membrane anchorage of gp160 is necessary and sufficient to prevent CD4 transport to the cell surface.
    Martin RA; Nayak DP
    Virology; 1996 Jun; 220(2):473-9. PubMed ID: 8661397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lectin-carbohydrate interactions and infectivity of human immunodeficiency virus type 1 (HIV-1).
    Gattegno L; Ramdani A; Jouault T; Saffar L; Gluckman JC
    AIDS Res Hum Retroviruses; 1992 Jan; 8(1):27-37. PubMed ID: 1736938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulfation of the human immunodeficiency virus envelope glycoprotein.
    Bernstein HB; Compans RW
    J Virol; 1992 Dec; 66(12):6953-9. PubMed ID: 1433500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between high level gp160 expression and reduced CD4 biosynthesis in clonal derivatives of human immunodeficiency virus type 1-infected U-937 cells.
    Geleziunas R; Bour S; Wainberg MA
    J Gen Virol; 1994 Apr; 75 ( Pt 4)():857-65. PubMed ID: 8151301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analysis of HIV-1 recombinant envelope glycoproteins from different culture systems.
    Jeffs SA; Goriup S; Stacey G; Yuen CT; Holmes H
    Appl Microbiol Biotechnol; 2006 Sep; 72(2):279-90. PubMed ID: 16447052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational analysis of HIV-1 gp160-mediated receptor interference: intracellular complex formation.
    Martin RA; Nayak DP
    Virology; 1996 Jun; 220(2):461-72. PubMed ID: 8661396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.